NCT00650416View on ClinicalTrials.gov

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Healthy
Interventions
DRUG

Carvedilol Tablets 12.5 mg

12.5mg, single dose fasting

DRUG

Coreg® Tablets 12.5 mg

12.5mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY